Karin Wallander
Overview
Explore the profile of Karin Wallander including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ofverholm I, Lin Y, Mondini J, Hardingz J, Branstrom R, Tsagkozis P, et al.
Cancers (Basel)
. 2024 Nov;
16(22).
PMID: 39594770
Background: The etiology of most mesenchymal tumors is unknown, and knowledge about syndromes with an increased risk of tumors in bone or soft tissue is sparse. Methods: We present a...
2.
Ofverholm I, Wallander K, Haglund C, Chellappa V, Wejde J, Gellerbring A, et al.
Clin Cancer Res
. 2024 Apr;
30(12):2647-2658.
PMID: 38573684
Purpose: Tumor classification is a key component in personalized cancer care. For soft-tissue and bone tumors, this classification is currently based primarily on morphology assessment and IHC staining. However, these...
3.
Wallander K, Ofverholm I, Boye K, Tsagkozis P, Papakonstantinou A, Lin Y, et al.
J Intern Med
. 2023 Aug;
294(6):690-707.
PMID: 37643281
Sarcoma subtype classification is currently mainly based upon histopathological morphology. Molecular analyses have emerged as an efficient addition to the diagnostic workup and sarcoma care. Knowledge about the sarcoma genome...
4.
Wallander K, Haider Z, Jeggari A, Foroughi-Asl H, Gellerbring A, Lyander A, et al.
Cancers (Basel)
. 2023 Feb;
15(4).
PMID: 36831507
In this longitudinal study, cell-free tumour DNA (a liquid biopsy) from plasma was explored as a prognostic biomarker for gastro-oesophageal cancer. Both tumour-informed and tumour-agnostic approaches for plasma variant filtering...
5.
Wallander K, Thonberg H, Nilsson D, Tham E
Hered Cancer Clin Pract
. 2021 Nov;
19(1):47.
PMID: 34784949
No abstract available.
6.
Wallander K, Thonberg H, Nilsson D, Tham E
Hered Cancer Clin Pract
. 2021 Oct;
19(1):46.
PMID: 34711244
Multiple primary cancers, defined as three or more primary tumours, are rare, and there are few genetic studies concerning them. There is a need for increased knowledge on the heritability...
7.
Wallander K, Thutkawkorapin J, Sahlin E, Lindblom A, Lagerstedt-Robinson K
Hered Cancer Clin Pract
. 2021 Apr;
19(1):23.
PMID: 33827643
Background: We have previously reported a family with a suspected autosomal dominant rectal and gastric cancer syndrome without any obvious causative genetic variant. Here, we focused the study on a...
8.
Wallander K, Eisfeldt J, Lindblad M, Nilsson D, Billiau K, Foroughi H, et al.
PLoS One
. 2021 Feb;
16(2):e0245488.
PMID: 33539436
Background: Analysis of cell-free tumour DNA, a liquid biopsy, is a promising biomarker for cancer. We have performed a proof-of principle study to test the applicability in the clinical setting,...
9.
Wallander K, Liu W, von Holst S, Thutkawkorapin J, Kontham V, Forsberg A, et al.
Genes Chromosomes Cancer
. 2019 Jul;
58(11):775-782.
PMID: 31334572
Colorectal cancer (CRC), prostate cancer (PrC), and gastric cancer (GC) are common worldwide, and the incidence is to a certain extent dependent on genetics. We have recently shown that in...
10.
Catucci I, Osorio A, Arver B, Neidhardt G, Bogliolo M, Zanardi F, et al.
Genet Med
. 2017 Aug;
20(4):452-457.
PMID: 28837162
PurposeMonoallelic germ-line mutations in the BRCA1/FANCS, BRCA2/FANCD1 and PALB2/FANCN genes confer high risk of breast cancer. Biallelic mutations in these genes cause Fanconi anemia (FA), characterized by malformations, bone marrow...